Bhutan

Bhutan

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
2.62 (2.53 - 2.73) 2019 Modelled IHME
2.67 (2.57 - 2.77) 2018 Modelled IHME
2.74 (2.63 - 2.85) 2017 Modelled IHME
2.84 (2.74 - 2.95) 2016 Modelled IHME
2.97 (2.85 - 3.09) 2015 Modelled IHME
3.07 (2.95 - 3.19) 2014 Modelled IHME
3.17 (3.05 - 3.29) 2013 Modelled IHME
3.26 (3.14 - 3.39) 2012 Modelled IHME
3.36 (3.23 - 3.49) 2011 Modelled IHME
3.46 (3.32 - 3.60) 2010 Modelled IHME
3.57 (3.43 - 3.71) 2009 Modelled IHME
3.69 (3.54 - 3.83) 2008 Modelled IHME
3.81 (3.66 - 3.96) 2007 Modelled IHME
3.94 (3.77 - 4.09) 2006 Modelled IHME
4.07 (3.89 - 4.23) 2005 Modelled IHME
4.2 (4.02 - 4.36) 2004 Modelled IHME
4.34 (4.14 - 4.49) 2003 Modelled IHME
4.48 (4.27 - 4.64) 2002 Modelled IHME
4.62 (4.39 - 4.79) 2001 Modelled IHME
4.76 (4.50 - 4.95) 2000 Modelled IHME
4.92 (4.62 - 5.11) 1999 Modelled IHME
5.1 (4.73 - 5.31) 1998 Modelled IHME
5.27 (4.85 - 5.51) 1997 Modelled IHME
5.42 (4.95 - 5.68) 1996 Modelled IHME
5.53 (4.97 - 5.81) 1995 Modelled IHME
5.6 (5.06 - 5.88) 1994 Modelled IHME
5.67 (5.10 - 5.96) 1993 Modelled IHME
5.72 (5.13 - 6.01) 1992 Modelled IHME
5.76 (5.16 - 6.06) 1991 Modelled IHME
5.77 (5.17 - 6.08) 1990 Modelled IHME
4.29 (3.31 - 5.55) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.16 (0.13 - 0.17) 2019 Modelled IHME
0.16 (0.14 - 0.17) 2018 Modelled IHME
0.16 (0.14 - 0.18) 2017 Modelled IHME
0.17 (0.14 - 0.18) 2016 Modelled IHME
0.17 (0.14 - 0.19) 2015 Modelled IHME
0.18 (0.15 - 0.20) 2014 Modelled IHME
0.2 (0.16 - 0.22) 2013 Modelled IHME
0.21 (0.18 - 0.24) 2012 Modelled IHME
0.22 (0.19 - 0.25) 2011 Modelled IHME
0.23 (0.20 - 0.26) 2010 Modelled IHME
0.23 (0.20 - 0.26) 2009 Modelled IHME
0.23 (0.19 - 0.25) 2008 Modelled IHME
0.22 (0.19 - 0.25) 2007 Modelled IHME
0.22 (0.19 - 0.25) 2006 Modelled IHME
0.22 (0.19 - 0.25) 2005 Modelled IHME
0.23 (0.20 - 0.26) 2004 Modelled IHME
0.28 (0.24 - 0.31) 2003 Modelled IHME
0.35 (0.31 - 0.39) 2002 Modelled IHME
0.45 (0.39 - 0.50) 2001 Modelled IHME
0.57 (0.49 - 0.63) 2000 Modelled IHME
1.01 (0.86 - 1.13) 1999 Modelled IHME
1.9 (1.60 - 2.13) 1998 Modelled IHME
2.93 (2.44 - 3.29) 1997 Modelled IHME
3.79 (3.12 - 4.27) 1996 Modelled IHME
4.21 (3.39 - 4.76) 1995 Modelled IHME
4.28 (3.49 - 4.81) 1994 Modelled IHME
4.35 (3.54 - 4.86) 1993 Modelled IHME
4.39 (3.57 - 4.91) 1992 Modelled IHME
4.42 (3.58 - 4.96) 1991 Modelled IHME
4.43 (3.56 - 5.01) 1990 Modelled IHME
0.81 (0.55 - 1.22) 2015 Modelled WHO
Showing out of
Show more

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
25 (18 - 33) 2019 Modelled IHME
25 (18 - 33) 2018 Modelled IHME
25 (18 - 33) 2017 Modelled IHME
25 (18 - 33) 2016 Modelled IHME
25 (18 - 33) 2015 Modelled IHME
25 (19 - 33) 2014 Modelled IHME
25 (19 - 33) 2013 Modelled IHME
25 (19 - 33) 2012 Modelled IHME
25 (19 - 33) 2011 Modelled IHME
25 (19 - 33) 2010 Modelled IHME
25 (19 - 34) 2009 Modelled IHME
26 (20 - 35) 2008 Modelled IHME
27 (20 - 35) 2007 Modelled IHME
28 (21 - 36) 2006 Modelled IHME
28 (21 - 37) 2005 Modelled IHME
28 (21 - 36) 2004 Modelled IHME
28 (21 - 37) 2003 Modelled IHME
28 (21 - 37) 2002 Modelled IHME
28 (21 - 36) 2001 Modelled IHME
28 (21 - 37) 2000 Modelled IHME
29 (22 - 37) 1999 Modelled IHME
29 (22 - 38) 1998 Modelled IHME
29 (22 - 38) 1997 Modelled IHME
29 (22 - 38) 1996 Modelled IHME
30 (22 - 39) 1995 Modelled IHME
30 (23 - 39) 1994 Modelled IHME
30 (23 - 39) 1993 Modelled IHME
30 (23 - 39) 1992 Modelled IHME
31 (23 - 39) 1991 Modelled IHME
31 (23 - 40) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
96 2018 Survey/reported WHO/UNICEF
95 2017 Survey/reported WHO/UNICEF
82 2016 Survey/reported WHO/UNICEF
78 2015 Survey/reported WHO/UNICEF
78 2014 Survey/reported WHO/UNICEF
64 2013 Survey/reported WHO/UNICEF
60 2012 Survey/reported WHO/UNICEF
29 2011 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
97 2018 Survey/reported WHO/UNICEF
98 2017 Survey/reported WHO/UNICEF
98 2016 Survey/reported WHO/UNICEF
99 2015 Survey/reported WHO/UNICEF
99 2014 Survey/reported WHO/UNICEF
97 2013 Survey/reported WHO/UNICEF
97 2012 Survey/reported WHO/UNICEF
95 2011 Survey/reported WHO/UNICEF
91 2010 Survey/reported WHO/UNICEF
93 2009 Survey/reported WHO/UNICEF
96 2008 Survey/reported WHO/UNICEF
95 2007 Survey/reported WHO/UNICEF
95 2006 Survey/reported WHO/UNICEF
95 2005 Survey/reported WHO/UNICEF
89 2004 Survey/reported WHO/UNICEF
95 2003 Survey/reported WHO/UNICEF
83 2002 Survey/reported WHO/UNICEF
89 2001 Survey/reported WHO/UNICEF
98 2000 Survey/reported WHO/UNICEF
90 1999 Survey/reported WHO/UNICEF
81 1998 Survey/reported WHO/UNICEF
84 1997 Survey/reported WHO/UNICEF
16 1996 Survey/reported WHO/UNICEF
Showing out of
Show more

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
HCV testing policy
No
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.85 (0.69 - 1.04) 2019 Modelled IHME
0.85 (0.69 - 1.04) 2018 Modelled IHME
0.85 (0.69 - 1.04) 2017 Modelled IHME
0.84 (0.69 - 1.03) 2016 Modelled IHME
0.84 (0.68 - 1.03) 2015 Modelled IHME
0.84 (0.68 - 1.03) 2014 Modelled IHME
0.84 (0.68 - 1.03) 2013 Modelled IHME
0.84 (0.68 - 1.03) 2012 Modelled IHME
0.84 (0.68 - 1.03) 2011 Modelled IHME
0.85 (0.68 - 1.04) 2010 Modelled IHME
0.85 (0.68 - 1.04) 2009 Modelled IHME
0.85 (0.69 - 1.05) 2008 Modelled IHME
0.86 (0.69 - 1.05) 2007 Modelled IHME
0.86 (0.69 - 1.06) 2006 Modelled IHME
0.86 (0.69 - 1.07) 2005 Modelled IHME
0.85 (0.69 - 1.04) 2004 Modelled IHME
0.82 (0.67 - 0.99) 2003 Modelled IHME
0.78 (0.64 - 0.94) 2002 Modelled IHME
0.75 (0.62 - 0.90) 2001 Modelled IHME
0.74 (0.61 - 0.89) 2000 Modelled IHME
0.74 (0.61 - 0.89) 1999 Modelled IHME
0.75 (0.61 - 0.89) 1998 Modelled IHME
0.75 (0.62 - 0.91) 1997 Modelled IHME
0.76 (0.62 - 0.91) 1996 Modelled IHME
0.76 (0.63 - 0.92) 1995 Modelled IHME
0.76 (0.63 - 0.92) 1994 Modelled IHME
0.77 (0.63 - 0.92) 1993 Modelled IHME
0.77 (0.63 - 0.93) 1992 Modelled IHME
0.77 (0.63 - 0.93) 1991 Modelled IHME
0.77 (0.63 - 0.93) 1990 Modelled IHME
Showing out of
Show more

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
32 (23 - 41) 2019 Modelled IHME
32 (23 - 41) 2018 Modelled IHME
32 (23 - 42) 2017 Modelled IHME
32 (23 - 41) 2016 Modelled IHME
32 (23 - 41) 2015 Modelled IHME
32 (23 - 41) 2014 Modelled IHME
32 (23 - 41) 2013 Modelled IHME
31 (23 - 40) 2012 Modelled IHME
31 (23 - 40) 2011 Modelled IHME
31 (23 - 40) 2010 Modelled IHME
31 (22 - 40) 2009 Modelled IHME
30 (22 - 39) 2008 Modelled IHME
30 (22 - 39) 2007 Modelled IHME
30 (21 - 39) 2006 Modelled IHME
29 (21 - 38) 2005 Modelled IHME
29 (21 - 37) 2004 Modelled IHME
29 (20 - 37) 2003 Modelled IHME
28 (20 - 37) 2002 Modelled IHME
28 (20 - 36) 2001 Modelled IHME
28 (20 - 36) 2000 Modelled IHME
28 (20 - 36) 1999 Modelled IHME
27 (19 - 35) 1998 Modelled IHME
27 (19 - 35) 1997 Modelled IHME
27 (19 - 35) 1996 Modelled IHME
27 (19 - 35) 1995 Modelled IHME
26 (19 - 35) 1994 Modelled IHME
26 (18 - 35) 1993 Modelled IHME
26 (18 - 35) 1992 Modelled IHME
26 (18 - 35) 1991 Modelled IHME
26 (18 - 35) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
300 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
HCV testing policy
No
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
2.62 (%)
2019
(2.53 - 2.73(%))
IHME
HCV (RNA/cAg+)
0.85 (%)
2019
(0.69 - 1.04(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
53
2019
(33 - 95)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
51
2019
(32 - 88)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.16 (%)
2019, latest modelled
(0.13 - 0.17(%))
IHME

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
96 (%)
2018
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines